Results 111 to 120 of about 14,687 (202)

3.1 Analysis of Raynaud’s phenomenon in an infant and teenage population 3 Connective tissue disorders [PDF]

Annals of the Rheumatic Diseases, 2000
ML GÀMIR, MJ RUBIRA, CM VÀZQUEZ, M REVENGA, R HORTAL, P QUARTIER, D BONNET, JC FOURNET, C BODEMER, PH ACAR, M OUACHÉE, AM PRIEUR, AG CLEARY, JA SILLS, E BAILDAM, JE DAVIDSON, ML GÀMIR, MJ RUBIRA, CM VÀZQUEZ, M REVENGA, R HORTAL, P QUARTIER, D BONNET, JC FOURNET, C BODEMER, PH ACAR, M OUACHÉE, AM PRIEUR, P DOLEZALOVA, P TELEKESOVA, D NEMCOVA, J HOZA, ML GÀMIR, MJ RUBIRA, CM VÀZQUEZ, M REVENGA, R HORTAL, P QUARTIER, D BONNET, JC FOURNET, C BODEMER, PH ACAR, M OUACHÉE, AM PRIEUR, A RAVELLI, C MALATTIA, F TEMPORINI, S MAGNI MANZONI, C MORETTI, G ROSSI, L BASSI, A MARTINI   +51 more
openaire   +1 more source

Evaluating heterogeneity in MDA‐5+ dermatomyositis through cluster analyses

Journal of the European Academy of Dermatology and Venereology, EarlyView.
David R. Pearson
wiley   +1 more source

Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile

Journal of Internal Medicine, Volume 299, Issue 2, Page 228-240, February 2026.
Abstract Objectives Anti‐MDA5 dermatomyositis (anti‐MDA5 DM) is the most severe subtype of dermatomyositis, due to its pulmonary involvement. Current treatment involves corticosteroids and immunosuppressants, but variability in responses exists. This study aims to evaluate the efficacy and safety of Janus kinase (JAK)– and calcineurin–inhibitor ...
Valentine Pagis, Quentin Astouati, Lucas Pacoureau, Yann Nguyen, Pierre Bay, Antoine Roux, Laure Gallay, Vincent Cottin, Benjamin Terrier, Alain Meyer, Charles Cerf, Mathilde Neuville, Baptiste Hervier, Arthur Renaud, Benoit Suzon, Nicolas Schleinitz, Thomas Papo, Pascaline Priou, Arsène Mekinian, Audrey Ullmer, Erwan Oehler, Noémie Gensous, Alice Berezne, Luc De Saint Martin, Thierry Marhadour, Mickaël Martin, Amélie Servettaz, Maxime Samson, Laurent Gilardin, Pierre Charles, Juliette Woessner, Thierry Carmoi, Baptiste Dilly, Wladimir Mauhin, Nicolas Baillet, Sébastien Humbert, Benjamin Thoreau, Marine Lemaitre, Claire Le Pendu, Pierre Loiseau, Thomas Quemeneur, Elodie Blanchard, Nicol Voermans, David Launay, Hilario Nunes, Olivier Benveniste, Yurdagul Uzunhan, Yves Allenbach   +47 more
wiley   +1 more source

Drug initiation and escalation strategies of vasodilator therapies for Raynaud’s phenomenon: can we treat to target? [PDF]

, 2019
Michael Hughes, Dinesh Khanna, John D Pauling   +2 more
openalex   +1 more source

Fenómeno de Raynaud Raynaud's Phenomenon

Angiologia e Cirurgia Vascular, 2011
O Fenómeno de Raynaud (FR) é uma manifestação clínica comum, traduzida por vasoespasmos recorrentes dos dedos, na maioria das vezes provocados pela exposição ao frio ou estímulos emocionais. Pode ser primário (idiopática) ou secundária a diversas doenças
Ivone Silva, Tiago Loureiro, Isabel Almeida, Armando Mansilha, Rui Almeida, Carlos Vasconcelos   +5 more
doaj  

Botulinum Toxin for the Treatment of Raynaud’s Conditions of the Hand: Clinical Practice Updates and Future Directions

Toxins
Raynaud’s conditions of the hand, referred to commonly as Raynaud’s phenomenon, both primary and secondary, represents a spectrum of disorders affecting the digits, characterised by recurrent episodes of vasospasm that result in a triad of symptoms: pain,
Patrick O’Donohoe, Jake McDonnell, Justin Wormald, Lylas Aljohmani, Kevin Cronin, Laura Durcan, Oran Kennedy, Roisin Dolan   +7 more
doaj   +1 more source

To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud’s phenomenon in South Korea; Korean Raynaud study (KOARA study) [PDF]

, 2009
Whan-Seok Choi, Chang-Jin Choi, Kyung Soo Kim, Jae‐Ho Lee, Chan-Hee Song, Ju‐Hye Chung, Sun-Myeoung Ock, Jung-Bok Lee, Chul-Min Kim   +8 more
openalex   +1 more source

Glomus Tumor Presenting as Raynaud's Phenomenon

Case Reports in Medicine, 2012
Glomus tumors are rare tumors that often include hands and feet; they present characteristically with paroxysmal pain, exquisite point tenderness, and cold sensitivity.
M. H. Abdelrahman, M. Hammoudeh
doaj   +1 more source

A woman with dysphagia and Raynaud’s phenomenon [PDF]

, 2002
Daniel R. Gaya, Robert Mactier
openalex   +1 more source

Efficacy of Botulinum Toxin B Injection for Raynaud’s Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis

Acta Dermato-Venereologica, 2017
The efficacy and safety of botulinum toxin B (BTX-B) for treatment of Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis was assessed.
Sei-ichiro Motegi, Akihito Uehara, Kazuya Yamada, Akiko Sekiguchi, Chisako Fujiwara, Sayaka Toki, Yuki Date, Tetsuya Nakamura, Osamu Ishikawa   +8 more
doaj   +1 more source